{"news_desk": "Business", "print_page": "19", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Food and Drug Administration approves Corlanor, drug used to treat chronic heart failure that has shown mixed results in clinical trials.", "type_of_material": "News", "word_count": "633", "lead_paragraph": "Many Wall Street analysts and heart specialists are lukewarm about the drug, which has shown mixed results in clinical trials.", "pub_date": "2015-04-16T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "F.D.A. Approves Amgen Drug to Treat Heart Failure", "print_headline": "F.D.A. Approves Drug to Treat Heart"}, "snippet": "Many Wall Street analysts and heart specialists are lukewarm about the drug, which has shown mixed results in clinical trials.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/04/16/business/fda-approves-amgen-drug-to-treat-heart-failure.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Heart", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Amgen Inc", "name": "organizations"}], "blog": [], "_id": "552ee37438f0d824112d66f5", "source": "The New York Times"}